Similarly, in our model, the dual challenge of hyperglycemia and GBS may trigger a tolerization-like response, selectively downregulating TNF-α, MCP-1, and MIP-1β to avoid fetal harm, yet at the cost of impaired immune defense. This evidence concerns the gene CCL2 and Hyperglycemia.